Marianne has broad experience in the life sciences sector, having worked across biotechnology and biopharmaceuticals companies. She has built a transversal career spanning quality assurance, operational excellence, corporate communication, investor relations and human resources. This combination enables her to connect scientific, regulatory, and strategic dimensions to support organizational growth and transformation. Prior experience: • Corporate …
Archives du type de publication : Team Showcase
Florian Sourd
Florian has over 10 years of experience in corporate finance and financial services. Florian was involved more specifically in healthcare transactions for diagnostic companies and healthcare provider group. Prior experience: • Manager in Transaction Services, Deloitte (2015-2019) • Chief Financial Officer, OnyxT+ (2014-2015) • Senior in Financial Audit, EY (2012-2014) • M&A Analyst, BNP Paribas …
Vincent Monchois
Vincent has over 20 years of experience in bioprocess development and manufacturing, with deep expertise spanning recombinant proteins, monoclonal antibodies, vaccines and gene therapies. He has held senior leadership roles in biotech and CDMO environments, where he managed cross-functional teams, led large-scale CMC programs from early discovery to late-stage clinical supply, and supported global regulatory …
Prof. Pierre Vandamme, MD, PhD
Prof. Pierre Van Damme is the former Chairman of the Vaccine & Infectious Disease Institute (VAXINFECTIO) at the University of Antwerp, and head of the Centre for the Evaluation of Vaccination with more than 25 years of experience in vaccinology Expertise: • Conducted more than 350 vaccine trials at the Center for the Evaluation of …
Prof. Odile Launay, MD, PhD
Odile Launay is Professor of Infectious diseases at the University of Paris. She is the Director of the Clinical Investigation Center in Vaccinology (CIC Cochin Pasteur), the only French clinical investigation center dedicated to vaccinal research based in Paris, since it is creation in 2005 and Coordinator of the French Innovative Clinical Network in Vaccinology …
Dr W. Ripley Ballou, MD
Dr W. Ripley Ballou currently serves as Principal Investigator for the ADVANCE Program at IAVI, he also held several leadership positions at GSK Vaccines globally and in the US, and with the Gates Foundation. Rip brings over 30 years of experience in the clinical development of vaccines. Expertise: • Experience with multiple clinical development for …
Dr Bernard Fritzell, MD
Dr Bernard Fritzell is an independent consultant with 35 years’ experience in the clinical development of vaccines Expertise: • Major Contributions to the understanding of polysaccharide conjugate vaccines including Haemophilus influenza type B, meningococcal group A & C and Streptococcus pneumoniae and associated vaccination strategies • Contributions to the clinical development of Hepatitis B, rabies …
Prof. Geert Leroux-Roels, MD, PhD
Prof. Geert Leroux-Roels is an Emeritus professor of Ghent University, Faculty of Medicine & Health Science, founder and former director of the Center for Vaccinology (CEVAC) at Ghent University and University Hospital. He acts as a private consultant and keeps supporting CEVAC activities as clinical investigator and scientific advisor. Expertise: • Conducted more than 250 …
Prof. Sir Andrew J McMichael
Sir Andrew J MCMICHAEL is a Professor of Molecular Medicine at the Nuffield Department of Medicine at the University of Oxford, UK. For more than 50 years he has worked on cytotoxic T-lymphocytes (CTL) responses against viruses, especially influenza. • He first showed that human cytotoxic T lymphocyte (CTL) responses to influenza virus were HLA …
Dr. Tim Mosmann
Dr. Tim Mosmann is Director of the human immunology center at the University of Rochester, with more than 40 years of experience and major contributions in T cell mediated immunity Expertise • Established a high-throughput proliferation and cytotoxicity assay for cytokines • Used this assay to show that there were discrete patterns of cytokines produced …